CSII Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 Apr 2023 @ 22:00):

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally...

Stats
Tagesvolumen	387 776
Durchschnittsvolumen	677 842
Marktkapitalisierung	843.96M
EPS	$0 ( 2024-02-07 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-20.83
ATR14	$0.103 (0.52%)

Insider Trading

Date	Person	Action	Amount	type
2023-04-27	Paulsen Erik	Sell	20 627	Restricted Stock Units
2023-04-27	Paulsen Erik	Sell	700	Common Stock
2023-04-27	Points Jeffrey S.	Sell	138 957	Common Stock
2023-04-27	Points Jeffrey S.	Sell	34 051	Common Stock
2023-04-27	Rempe Stephen J.	Sell	75 659	Common Stock

INSIDER POWER
-78.95
Last 100 transactions
Buy: 675 433 \| Sell: 1 911 221

Volumen Korrelation

Lang: 0.24 (neutral)

Kurz: -0.52 (weak negative)

Signal:(76.086) Neutral

Cardiovascular Systems Korrelation

10 Am meisten positiv korreliert
ATCX	0.992
TA	0.978
IIN	0.972
ECHO	0.968
SPRB	0.966
IFRX	0.963
LGMK	0.962
BUR	0.956
EZFL	0.948
SHC	0.947

10 Am meisten negativ korreliert
MDXH	-0.959
TENX	-0.952
SMH	-0.951
BSET	-0.948
SINT	-0.944
ONCT	-0.944
CYXT	-0.944
SIRI	-0.937
VTRU	-0.934
NDRA	-0.934

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Cardiovascular Systems Korrelation - Währung/Rohstoff

-0.38
( neutral )

0.42
( neutral )

0.57
( weak )

-0.16
( neutral )

0.09
( neutral )

0.36
( neutral )

Cardiovascular Systems Finanzdaten

Annual	2022
Umsatz:	$236.22M
Bruttogewinn:	$172.78M (73.14 %)
EPS:	$-0.940

FY	2022
Umsatz:	$236.22M
Bruttogewinn:	$172.78M (73.14 %)
EPS:	$-0.940

FY	2021
Umsatz:	$258.97M
Bruttogewinn:	$197.84M (76.39 %)
EPS:	$-0.350

FY	2020
Umsatz:	$236.55M
Bruttogewinn:	$187.79M (79.39 %)
EPS:	$-0.790

Financial Reports:

No articles found.

Cardiovascular Systems

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.